Krishna's Ayurveda has introduced a new product, She Care Juice, which is clinically proven to support the management of Polycystic Ovary Disease (PCOD) within 90 days. This herbal formulation aims to address the growing concern of PCOD among women, offering a natural and effective alternative to conventional treatments.
Clinical Evidence and Efficacy
The She Care Juice has undergone rigorous clinical trials that demonstrate its efficacy in managing PCOD symptoms. The study showed significant improvements in hormonal balance, menstrual regularity, and reduction of ovarian cysts in participants over a 90-day period. The juice is formulated with a blend of traditional Ayurvedic herbs known for their therapeutic properties in women's health.
Key Ingredients and Benefits
The formulation includes herbs such as Ashoka, Lodhra, and Shatavari, which have been used in Ayurveda for centuries to support female reproductive health. These ingredients work synergistically to regulate hormones, reduce inflammation, and improve overall ovarian function. The juice is also rich in antioxidants, which help combat oxidative stress associated with PCOD.
Addressing a Common Health Issue
PCOD affects a significant percentage of women worldwide, often leading to symptoms like irregular periods, weight gain, acne, and infertility. Krishna's Ayurveda's She Care Juice offers a holistic approach, targeting the root causes rather than just alleviating symptoms. The product is free from harmful chemicals and additives, making it a safe option for long-term use.
Expert Recommendations
Ayurvedic practitioners recommend combining the juice with lifestyle modifications, including a balanced diet and regular exercise, for optimal results. The company emphasizes that while the juice is effective, it should be used as part of a comprehensive management plan under medical supervision.
Availability and Market Impact
The She Care Juice is now available across India through online platforms and select retail stores. Krishna's Ayurveda plans to expand distribution to international markets in the coming months. The launch is expected to strengthen the company's position in the women's health segment, which is witnessing increased demand for natural and clinically validated products.
